Related Experiment Video
Updated: May 21, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Global structure-activity relationship model for nonmutagenic carcinogens using virtual ligand-protein interactions
Albert R Cunningham1, C Alex Carrasquer, Shahid Qamar
1James Graham Brown Cancer Center, University of Louisville, Louisville, KY 40202, USA.
Structure-activity relationship (SAR) models predict carcinogenicity. Virtual ligand-protein interaction models show promise for nonmutagenic carcinogens, outperforming traditional fragment models for these specific compounds.
Area of Science:
- Toxicology and Cheminformatics
- Computational toxicology
- Structure-Activity Relationship (SAR) modeling
Background:
- Structure-activity relationship (SAR) models are crucial for understanding chemical carcinogen mechanisms and predicting carcinogenicity.
- Existing SAR models often struggle with nonmutagenic carcinogens, highlighting a need for improved predictive approaches.
Purpose of the Study:
- To compare a traditional fragment-based SAR approach with a novel virtual ligand-protein interaction-based approach for modeling nonmutagenic carcinogens.
- To evaluate the performance of these models using distinct learning sets, including data from the Carcinogenic Potency Database and rodent cancer bioassays.
Main Methods:
- Developed ligand-based SAR models utilizing computationally calculated ligand-binding affinities to 5495 proteins.
- Created two learning sets: one from the Carcinogenic Potency Database and another from Malacarne et al. for nonalerting compounds.
- Assessed model performance based on mutagenicity categorization and concordance rates for nonmutagenic/nonalerting carcinogens and noncarcinogens.
Main Results:
- The traditional fragment model outperformed the ligand-based model when rat cancer models were categorized by mutagenicity.
- For nonmutagenic or nonalerting compounds, the fragment model showed ~50% concordance, while ligand-based models achieved 71% (nonmutagenic) and 74% (nonalerting).
Conclusions:
- Virtual ligand-protein interaction analysis shows potential for developing predictive SAR models for nonmutagenic carcinogens.
- A hybrid approach, using fragment-based models for mutagenic chemicals and ligand-based models for nonmutagenic ones, may offer a practical strategy for carcinogenesis SAR modeling.
Related Concept Videos
Mutagenicity and Carcinogenicity
Ligand Binding Sites
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Ligand Binding Sites
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Ligand Binding and Linkage
Ligand Binding and Linkage
